Panelists

Aida Habtezion, M.D., MSc, FRCPC, AGAF 

Chief Medical Officer and Head of Worldwide Medical & Safety, Pfizer

As Chief Medical Officer of Pfizer, Dr. Habtezion leads Pfizer's Worldwide Medical & Safety organization responsible for ensuring that patients, physicians, and regulatory agencies are provided with information on the safe and appropriate use of Pfizer medications. With her team, she leads Pfizer’s Institute of Translational Equitable Medicine (ITEM), an initiative spanning across key research, development, and medical activity dimensions to close gaps in health disparity by leveraging science, data, and translational expertise to integrate equity across Pfizer’s end-to-end development pipeline.

Prior to joining Pfizer, she was a practicing physician, scientist, a tenured and endowed Professor of Medicine, at Stanford University. She led a large translational research lab funded by multiple NIH, DOD, and foundation grants focused on understanding disease mechanisms in pancreatic and intestinal inflammatory diseases and authored over a hundred high impact publications in top peer-reviewed journals. She also served as an Associate Dean for Academic Affairs in the School of Medicine, a faculty member in Stanford's Immunology Ph.D. program, Neuroscience Institute, Cancer Institute, Bio-X interdisciplinary biosciences institute, Maternal & Child Health Research Institute, and faculty fellow at Stanford's ChEM-H (Chemistry, Engineering & Medicine for Human Health). She served in multiple national and international scientific study sections and editorial boards. 

She is a Fellow of the American Gastroenterological Association, an Allen Distinguished Investigator, the American Pancreas Association past President, an elected member of the American Society for Clinical Investigation (ASCI) and the Association of American Physicians (AAP). 

Dr. Jean Claude Mugunga

Deputy Chief Medical Officer, Partners in Health

Dr Jean Claude Mugunga is a physician leader currently serving as the Deputy Chief Medical Officer of Partners In Health, where he leads the organization’s work related to Population Health Management (health financing, planning, and outcomes measurement) towards achieving Universal Health Coverage in supported countries. His previous work experience includes working as a clinician at public facilities in Rwanda and a researcher for the Overseas Development Institute, UK, before joining PIH in 2013. He is a faculty member in the Division of Global Health Equity at Brigham & Women’s Hospital, as well as a Lecturer in Department of Global Health and Social Medicine at Harvard Medical School, and at the University of Global Health Equity in Rwanda. Dr Mugunga obtained his medical degree from the University of Rwanda and a Master of Science in Global Health Policy and Management from Brandeis University.

Jami Taylor

Vice President Corporate Affairs, Protagonist Therapeutics

Jami Taylor is Vice President of Corporate Affairs at Protagonist Therapeutics, a biotechnology company working to develop transformative, accessible medicines capable of displacing older treatment modalities with high infrastructure requirements that implicitly limit access. She is also a Global Justice Fellow at Yale University, working to design new models to improve access to medicines in the world's poorest and most challenging settings. Earlier in her career, Jami held global leadership roles at Johnson & Johnson across key divisions and was a founding member of Johnson & Johnson Global Public Health.

Jami has served as a member of the National Academy of Medicine Forum on Microbial Threats; the Private Sector Delegation to the Global Fund to Fight AIDS, Tuberculosis, and Malaria; the Chairman’s Circle at the Center for Global Development; the Global Health Advisory Council at Harvard Medical School; and on many other committees and forums addressing priority issues in medicine and society. In 2014, Jami was named a Cross-Sector Leadership Fellow at the Presidio Institute, a program created by the White House Office of Social Innovation and Civic Participation to advance the work of leaders addressing society’s most complex challenges.

 Jami holds degrees from the Kellogg School of Management at Northwestern University, Harvard University, and the University of Virginia. 

Khan M. Siddiqui, MD

Chief Medical Officer and Chief Strategy Officer, Hyperfine

Dr. Siddiqui is a serial entrepreneur, a radiologist, and currently the chief medical officer and chief strategy officer for Hyperfine, Inc. This groundbreaking company created the world’s first FDA 510(k)-cleared, portable MRI system. Dr. Siddiqui led multiple funding rounds for Hyperfine and helped take the company public (listed on NASDAQ as $HYPR). To date, and through Dr. Siddiqui’s leadership, Hyperfine has submitted more than 120 issued patents and 285 pending applications.

In addition, Dr. Siddiqui is the founder and executive chairman of HOPPR, a data and deep learning as a service platform that enables data liquidity to accelerate and scale AI application development. Before joining Hyperfine, Dr. Siddiqui founded Higi, a consumer health technology company acquired by Babylon Health as part of a $4.2 billion SPAC transaction. Higi stations are deployed in over 12,000 locations globally, with over 60 million patients on the platform.

Dr. Siddiqui holds dozens of patents for deep learning, AI, image processing, data visualization, MR imaging, and secure patient information handling and health records technologies. He has focused on using advancements in technology—namely computing power, microelectronics, connectivity, big data, and AI—to democratize technologies in healthcare to make solutions better, smaller, cheaper, and more accessible to clinicians and patients globally.

Before founding Higi, Dr. Siddiqui was a physician executive at Microsoft, where he was responsible for platform engineering and AI for the health solutions group. His Microsoft legacy includes stimulating computer vision and machine learning research that led to the development of the regression forest algorithms, which became the foundation technology in the Xbox Kinect. Dr. Siddiqui was also responsible for developing Microsoft’s cloud (Azure) based medical imaging products and infrastructure.

Before joining Microsoft, Dr. Siddiqui was director of the Center for Biomedical Imaging and Informatics at Johns Hopkins University, program director of imaging informatics and MRI fellowship programs at the University of Maryland, and the founding chair of the American College of Radiology’s Imaging and Informatics Commission. He is a graduate of the Aga Khan University Medical College in Pakistan, completed his training in medicine at New York University, training for radiology at Geisinger Medical Center in Danville, Pennsylvania, and his fellowship in imaging informatics at the University of Maryland in Baltimore, Maryland. Dr. Siddiqui has published dozens of peer-reviewed papers and has given hundreds of invited talks. Dr. Siddiqui is a board of directors member and an advisory board member for various worldwide startups and sits on various national committees on health care and medical imaging.

In his spare time, Dr. Siddiqui loves spending time with his family. He and his two sons often explore Chicago on bikes when not painting or SCUBA diving.

Moderator